CClinicalTrials.gg
CompletedNCT05765305Updated Mar 15, 2023

Combined Chromium With Letrozole Versus Letrozole Only in Induction of Ovulation in Patients With Polycystic Ovary Syndrome

An observational study in Polycystic Ovary Syndrome, sponsored by Cairo University. Completed at 1 site in Egypt. Open to female participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-03-15.

Sponsored by Cairo University · Observational

Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
90
Ages
18 Years to 35 Years
Sex
Female
01

Study summary

Combined letrozole with chromium versus letrozole only in induction of ovulation in polycystic ovary syndrome

Read the detailed description

Randomized controlled trial

02

Conditions studied

  • Polycystic Ovary Syndrome
03

In context

Polycystic Ovary Syndrome

944 studies on the registry are indexed under Polycystic Ovary Syndrome; 174 are open to participants now.

This study's enrollment of 90 is below the median of 118 across 223 observational studies indexed under Polycystic Ovary Syndrome.

Browse Polycystic Ovary Syndrome studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Female patients aged from 18 to 35 years

Inclusion criteria

  • female patients aged from 18 to 35 years Anovulatory cycles Pcos

Exclusion criteria

Exclusion Criteria:

  • female patients aged more than 35years Male factor of infertility Other factors of infertility than pcos
05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
90 participants (actual)
Patient registry
No

Groups and cohorts

  • Letrozole

    Letrozole versus letrozole with chromium

    Drug: Letrozole with chromium

Interventions

  • DrugLetrozole with chromium

    Letrozole versus letrozole with chromium

06

What researchers measure

Primary outcomes

  1. Efficacy of letrozole

    efficacy of letrozole with chromium in improving induction of ovulation

    Time frame: 12 months

Secondary outcomes

  1. Miscarriage rate

    Incidence of OHSS

    Time frame: 12 months

07

Study locations

1 site
  • Faculty of medicine
    Cairo, القاهره, Egypt
08

References and documents

Individual participant data

Plan to share: No — Now no plan

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 15, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05765305
Lead sponsor
Cairo University
Responsible party
Mohammed salah Nasr (Clinical professor, Cairo University) — Principal investigator
First posted
Mar 13, 2023
Start date
Sep 1, 2018
Primary completion
Oct 1, 2019
Completion
Oct 1, 2019
Last update
Mar 15, 2023

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion